NDC 72511-393 – Repatha

Evolocumab 140 mg/mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC72511-393

Product details

Brand name
Repatha
Generic name
Evolocumab
Labeler
Amgen USA Inc.
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
BLA · BLA125522
Marketed since
November 24, 2024
Listing expires
December 31, 2027
Pharmacologic class
PCSK9 Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Repatha →

Package NDC codes (3)

Package NDCDescriptionSince
72511-393-011 SYRINGE in 1 CARTON (72511-393-01) / 1 mL in 1 SYRINGENov 24, 2024
72511-393-022 SYRINGE in 1 CARTON (72511-393-02) / 1 mL in 1 SYRINGENov 24, 2024
72511-393-96 sample1 SYRINGE in 1 CARTON (72511-393-96) / 1 mL in 1 SYRINGENov 24, 2024

Other Repatha products